Ghodke-Puranik, Yogita
Jin, Zhongbo
Zimmerman, Kip D.
Ainsworth, Hannah C.
Fan, Wei
Jensen, Mark A.
Dorschner, Jessica M.
Vsetecka, Danielle M.
Amin, Shreyasee
Makol, Ashima
Ernste, Floranne
Osborn, Thomas
Moder, Kevin
Chowdhary, Vaidehi
Langefeld, Carl D.
Niewold, Timothy B. http://orcid.org/0000-0003-3532-6660
Funding for this research was provided by:
National Institutes of Health (AR060861, AR057781, AR065964, AI071651)
Colton Center for Autoimmunity
Lupus Research Alliance
Lupus Research Foundation
U.S. Army (W81XWH-20-1-0686)
Article History
Received: 5 April 2021
Accepted: 17 October 2021
First Online: 30 November 2021
Declarations
:
: The institutional review board at the Mayo Clinic approved the study, and all patients provided informed consent.
: All authors have reviewed the final manuscript and approve of the submission for publication.
: TBN has received research grants from EMD Serono, Inc., and has consulted for Thermo Fisher, Progenetec, Roivant Sciences, Ventus, Toran, and Inova, all unrelated to the current manuscript. Other authors have no conflict of interest to declare.